Goat Milk

Phase 1Small molecule

Goat Milk is one of 8 small molecule programs targeting Allogeneic Hematopoietic Stem Cell Transplant Recipient. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Allogeneic Hematopoietic Stem Cell Transplant RecipientActive, not recruiting

Allogeneic Hematopoietic Stem Cell Transplant RecipientPhase 1

Active, not recruiting

Competition

Competitive Landscape

7 competitors in Allogeneic Hematopoietic Stem Cell Transplant Recipient

#DrugCompanyPhaseTrials

Recombinant Human GM-CSF

EEastern Cooperative Oncology Group

Phase 3

1 2

Kepivance

SSwedish Orphan Biovitrum

Phase 1

1 3

Rapamune

PPrism Pharmaceuticals

Phase 1

1 4

Prograf

VVeloxis Pharmaceuticals

Phase 1

1 5

Vepesid

AAvyxa

Phase 1

1 6

Cytoxan

BBaxter Healthcare Corporation

Phase 1

1 7

Shingrix

SShenzhen Shenxin Biotechnology Co., Ltd

Phase 2

1 8

Goat Milk

CCity of Hope Medical Center

Phase 1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Stem Cell Transplant1 trial

Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Withdrawn·—·Phase 1·NCT03531281

Allogeneic Hematopoietic Stem Cell Transplant Recipient1 trial

A Randomized Pilot Study of Human Lysozyme Goat Milk in Recipients of Standard Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation

Active, not recruiting·CCity of Hope Medical Center·Phase 1·NCT04177004·52 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Goat Milk. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Goat Milk compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Goat Milk. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — City of Hope Medical Center company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: CCity of Hope Medical Center

Goat Milk

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Stem Cell Transplant1 trial

Allogeneic Hematopoietic Stem Cell Transplant Recipient1 trial

References

Drug Info

Quick Facts

Related News